Arthur Kleinman, Professor of Medical Anthropology, Department of Global Health and Social Medicine, Harvard Medical School
Xiao Shuiyuan, Professor, Central South University, Xianya School of Public Health
Yifeng Xu, President, Shanghai Mental Health Center; Head & Professor, Department of Psychiatry, Shanghai Jiao Tong University School of Medicine; Director, WHO/Shanghai Collaborating Center for Research and Training in Mental Health
Vikram Patel, The Pershing Square Professor of Global Health and Wellcome Trust Principal Research Fellow, Department of Global Health and Social Medicine, Harvard Medical School; Professor, Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Co-Founder and Member of Managing Committee, Sangath
Karestan Koenen, Professor of Psychiatric Epidemiology, Department of Epidemiology and Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health
Host and Commentator
Winnie Yip, Professor of Global Health Policy and Economics, Harvard T.H. Chan School of Public Health; Director, Harvard China Health Partnership; Acting Director, Fairbank Center for Chinese Studies
This is a Fairbank Center Director’s Seminar. This event is sponsored by the Fairbank Center for Chinese Studies and the Harvard China Health Partnership, and co-sponsored by the Lakshmi Mittal and Family South Asia Institute.
COVID-19 has claimed many lives in the world. It has also caused catastrophic economic, social, and psychological costs that have far-reaching implications on human welfare. This session examines the effects of COVID-19 on the economy of China, the first country hit by COVID-19 and the first major economy that is gradually re-opening.
Panelists: Hongqiao Fu, Assistant Professor in Health Economics and Policy in School of Public Health, Peking University Ajay Nair, Co-founder, MeraDoctor Atveev Mehrotra, Associate Professor of Health Care Policy, Harvard Medical School
Moderator: Winnie Chi-Man Yip, Professor of Global Health Policy and Economics, Harvard School of Public Health; Director, Harvard China Health Partnership; Interim Director, Fairbank Center for Chinese Studies.
Sponsored by Fairbank Center for Chinese Studies and Harvard China Health Partnership. Co-sponsored by the Lakshmi Mittal and Family South Asia Institute and the Harvard University Asia Center. This panel discussion is presented as part of “24 Hours of Harvard,” a special feature of Worldwide Week at Harvard 2020.
This discussion will be streamed online. Check back soon for viewing information.
Tarun Khanna, Jorge Paulo Lemann Professor, Harvard Business School & Director, Lakshmi Mittal and Family South Asia Institute, Harvard University
Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations
Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd.
David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health
Through the lens of a contemporary case study, Harvard Business School Professor Tarun Khanna will share the geo-politics of how vaccines are developed, the funding and distribution methods that are critical to the effort, and the global alliances that facilitate this in the world today. He will speak with Dr. Gagandeep Kang, Executive Director, Translational Health Science and Technology Institute & Vice Chairperson of The Coalition for Epidemic Preparedness Innovations; Umang Vohra, Managing Director & Global Chief Executive Officer, Cipla Ltd, and Dr. David E. Bloom, Clarence James Gamble Professor of Economics & Demography, Harvard T.H. Chan School of Public Health, in a discussion on the South Asia context.
The objective is to share the mechanics and commerce of vaccine development and the critical role that science and business can play in combating pandemics such as COVID-19. The intent is to foster a collaborative and synchronous effort among science, business, and government to find synergies and solutions as they navigate the current challenges. How does one forge worldwide alliances in healthcare? How can science, business, government, and society collaborate on healthcare imperatives? How does one resolve the logistics and equity of vaccine distribution, and how can credibility and trust be built? This interactive conversation will be presented via Zoom web-conference.
“Outbreak: Epidemics in a Connected World”, an event jointly organized by The Lakshmi Mittal and Family South Asia Institute and the Harvard Global Health Institute and presented in New Delhi, examined the connections between human, animal and environmental health, and the response to disease outbreaks in India.
Location: Kresge G3, HSPH, 677 Huntington Avenue, Boston, MA
Rajani R. Ved is the Executive Director of National Health Systems Resource Centre in India’s Ministry of Health and Family Welfare and a Visiting Scientist at HSPH. For over ten years, she led the establishment and institutionalization of India’s ASHA community health worker program. Currently, she is leading the design and implementation support for India’s primary health care initiative, Ayushman Bharat Health and Wellness Centers.
Speaker: Dr. Rajani R. Ved, Executive Director, National Health Systems Resource Center, Ministry of Health and Family Welfare, Government of India
Moderator: Bhargav Krishna, Doctoral Candidate in Public Health, Harvard T.H. Chan School of Public Health; Adjunct Faculty, Public Health Foundation of India
This event is co-sponsored with the South Asian Students Association at Harvard T.H. Chan School of Public Health.
Join us for our ongoing India Seminar Series to discuss the growing challenge of Water Fluorosis, in a discussion titled, ‘Tackling Fluorosis: Innovative technology as a solution to the spreading health crisis’
There are about 66 million people in India suffering from toxic levels of fluoride in their drinking water, these are mostly poor people in rural communities in dry / arid area that must depend of groundwater as their drinking water source. Fluoride is a vicious toxic ion in the sense that it affects and attacks the poor far more aggressively that it affects those nutritionally better off. It also is very effective in ruining the lives of very young people who then suffer from serious bone deformation (skeletal fluorosis) and its harmful economic, social, and psychological effects.
The panelists for this discussion include,
– Dr. Andrew Z. Haddad- ITRI-Rosenfeld Postdoctoral Fellow, Lawrence Berkeley National Lab
– Srikrishna Sridhar Murthy- Founder and CEO, Sattva Consulting
– Dr. Sunderrajan Krishnan- Executive Director, INREM Foundation
Ramanan Laxminarayan, Vice President for Research and Policy at the Public Health Foundation of India; Director, Center for Disease Dynamics, Economics & Policy in Washington DC; Research Scholar and Lecturer at Princeton University
Professor Laxminarayan is Vice President for Research and Policy at the Public Health Foundation of India. He is an economist and epidemiologist by training. His research work deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems.
Prof Laxminarayan also directs the Center for Disease Dynamics, Economics & Policy in Washington DC, and is a Research Scholar and Lecturer at Princeton University.
Co-sponsored with the India Health Partnership in the Department of Global Health and Population, and the Harvard Global Health Institute
Omar Ishrak, Chairman and Chief Executive Officer, Medtronic
Discussant: Conor Walsh,Assistant Professor of Mechanical and Biomedical Engineering, Harvard School of Engineering and Applied Sciences
Chair: Tarun Khanna, Director, Harvard South Asia Institute,Jorge Paulo LemannProfessor, Harvard Business School
Over the last several decades, medical technology advancements have steadily improved the standard of care for patients in many areas of the world. At the same time, a huge disparity in access to high quality, cost-effective healthcare continues to exist for billions of people. The need in South Asia is particularly acute, with access to care limited to less than 10% of an estimated population of nearly 2 billion people. Innovation must address significant barriers, including a lack of patient awareness, infrastructure and training for healthcare professionals. Medtronic has started a unique program in India using a new business model to target a specific disease, define the full care continuum and build an ecosystem approach to address populations with little to no access to care. Addressing this huge challenge – and opportunity – requires a coordinated effort across multiple stakeholders to deliver innovation to improve outcomes, expand access and increase affordability of healthcare in South Asia.
Thomas Vallely, Senior Advisor, Mainland Southeast Asia, Ash Center, Harvard Kennedy School
Dr. Cynthia Maung, Director, Mae Tao Clinic, Thai-Burmese Border
Dr. Parveen K. Parmar, Harvard Humanitarian Initiative, Community Partners International
Phyu Phyu Saan, Senior Researcher, Global Justice Center, New York
Chair: Arthur Kleinman, Director, Harvard University Asia Center; Esther and Sidney Rabb Professor of Anthropology, Harvard University; Professor of Medical Anthropology and Professor of Psychiatry, Harvard Medical School
A billion people, or one-seventh of the world’s population, now live in slums in developing country cities. Mumbai, India, possibly has the world’s largest population of slum dwellers: 50-60% of its population lives in informal settlements on <9% of the city’s land area. A significant proportion of those slum residents live in “non-notified” settlements that lack any legal recognition, resulting in their exclusion from formal municipal services such as water, sanitation, and electricity. From 2009 to 2012, a team of researchers from PUKAR (a Mumbai-based research collective), the Harvard School of Public Health, and NYU engaged in an interdisciplinary project investigating health in a non-notified slum of 14,000 people. With support from the Weatherhead Center for International Affairs at Harvard, several new findings have emerged from these data in the last year that the research team wishes to disseminate to the public. This event will consist of a few short presentations of original research findings followed by reflections on the findings by professors from the Harvard School of Public Health and Harvard Graduate School of Design.
“Why Illegality is Deadly” Ramnath Subbaraman,PUKAR; Research Fellow in Medicine, Massachusetts General Hospital.
“A Novel Household Coding System and GPS Mapping for Facilitating Research and Advocacy” Dana Thomson,Research Associate in Global Health and Social Medicine, Harvard Medical School.
“Water Poverty in Slums: A Social Ecological Framework” Alpen Sheth,PhD Candidate, Department of Urban Studies and Planning, Massachusetts Institute of Technology.
“Measuring Water Poverty: Insights from Kaula Bandar” Laura Nolan,PhD Candidate in the Office of Population Research, Woodrow Wilson School of Public and International Affairs, Princeton University.
“Does Living in a Slum Take a Psychological Toll? Evidence and Reflections on Social Suffering in our Urbanizing World” Ramnath Subbaraman, PUKAR; Research Fellow in Medicine, Massachusetts General Hospital.
Reflections and Conversation:
David Bloom, Clarence James Gamble Professor of Economics and Demography, Department of Global Health and Population, Harvard School of Public Health.
Rahul MehrotraChair, Department of Urban Planning and Design; Professor of Urban Design and Planning, Harvard Graduate School of Design.
Sofi Bergkvist is the founding Managing Director of ACCESS Health International. ACCESS Health identifies, analyzes and supports in the design of healthcare service delivery and financing models for high quality and low-cost healthcare. She is also is a Senior Researcher at the Center for Emerging Markets Solutions at the Indian School of Business, where she focuses on health financing and public private partnerships in health.
Jerry La Forgia is a Lead Health Specialist at the World Bank. He devises policies and strategies, conducts policy dialogue with clients and designs and supervises Bank lending operations. He is also leading several policy research tasks in health. Dr. La Forgia specializes in health finance and management.